公开(公告)号：KR100878331B1

公开(公告)日：2009-01-14

申请号：KR1020070082438

申请日：2007-08-16

Applicant: 한국식품연구원 ,  한국화학연구원

Inventor： 권대영 ,  김명선 ,  구민선 ,  김순희 ,  양혜정 ,  김영섭 ,  유시용 ,  유미영

IPC: A61K31/343 ,  A61K36/87 ,  A61P3/04

Abstract: An anti-obesity pharmaceutical composition, and the anti-obesity food are provided to inhibit the differentiation of preadipocyte into adipocyte and to suppress the synthesis of cholesterol. An anti-obesity pharmaceutical composition comprises the extract of grape tree bark, or at least one component selected from the vitisin A represented by the formula 1, the vitisin B represented by the formula 2, the epsilon-viniferin represented by the formula 3 and the ampelopsin represented by the formula 4 which are separated from the extract of grape tree bark.

Abstract translation: 提供抗肥胖药物组合物和抗肥胖食品，以抑制前脂肪细胞分化成脂肪细胞并抑制胆固醇的合成。 抗肥胖药物组合物包含葡萄树皮提取物或选自由式1表示的维生素A，由式2表示的维生素B，由式3表示的ε-荧光素和 由葡萄树皮提取物分离的由式4表示的黄曲霉素。

公开(公告)号：KR101209889B1

公开(公告)日：2012-12-10

申请号：KR1020100045593

申请日：2010-05-14

Applicant: 한국식품연구원 ,  한국화학연구원

Inventor： 권대영 ,  황진택 ,  양혜정 ,  김성희 ,  박재호 ,  김영섭 ,  유시용 ,  연규환

IPC: A61K36/232 ,  A61K31/37 ,  A61P3/04 ,  A61P3/00

Abstract: 본발명은당귀의주성분인데쿠르신으로부터합성된유도체인데쿠시놀벤조에이트(Decursinol benzoate)를이용한비만예방용또는비만치료용조성물에관한것으로써, 보다상세하게는상기데쿠시놀벤조네이트는 AMPK(5' adenosine monophosphate-activated protein kinase)활성능을가짐으로써지방산합성을억제하는것을특징으로갖거나, PPAR-GAMMA(Peroxisome proliferator-activated receptor gamma)의발현및 전사활성을억제하는것을특징으로가질수 있다.

公开(公告)号：KR1020120003779A

公开(公告)日：2012-01-11

申请号：KR1020100064564

申请日：2010-07-05

Applicant: 한국식품연구원

Inventor： 황진택 ,  권대영 ,  성미정 ,  박재호 ,  양혜정 ,  김명선 ,  김현진 ,  허행전 ,  김영섭 ,  유시용

IPC: A61K36/185 ,  A61P3/04 ,  A61P3/00

Abstract: PURPOSE: A composition containing Pittosporum heterophyllum extract for preventing or treating obesity is provided to suppress differentiation of adipocytes and to activate AMPK(5'AMP-activated protein kinase). CONSTITUTION: A composition for preventing and treating obesity contains 0.1-99.9 wt% of Pittosporum heterophyllum extract as an active ingredient. The composition is a pharmaceutical composition or food additive composition. A food composition for preventing and treating obesity contains Pittosporum heterophyllum extract as an active ingredient. The composition is manufactured in the form of a pill, powder, granule, tablet, capsule, or beverage.

Abstract translation: 目的：提供含有用于预防或治疗肥胖症的Pittosporum heterophyllum提取物的组合物，以抑制脂肪细胞的分化并激活AMPK（5'AMP激活的蛋白激酶）。 构成：用于预防和治疗肥胖症的组合物含有0.1-99.9重量％的作为活性成分的Pittosporum heterophyllum提取物。 该组合物是药物组合物或食品添加剂组合物。 用于预防和治疗肥胖症的食物组合物含有作为活性成分的孔雀虱提取物。 组合物以丸剂，粉剂，颗粒剂，片剂，胶囊剂或饮料的形式制备。

公开(公告)号：KR1020100009151A

公开(公告)日：2010-01-27

申请号：KR1020080069892

申请日：2008-07-18

Applicant: 한국화학연구원 ,  한국식품연구원

Inventor： 김영섭 ,  유시용 ,  연규환 ,  홍경식 ,  이병회 ,  김성환 ,  유대석 ,  권대영 ,  성미정 ,  민용기

IPC: A61K36/78 ,  A61K36/539 ,  A61P19/10

CPC classification number: A61K36/539 ,  A61K36/78 ,  A61K2300/00

Abstract: PURPOSE: A composition containing mixture extract of Saururus chinensis and Scutellaria baicalensis is provided to suppress osteoclast differentiation, enhance bone density and bone content, and prevent or treat osteoporosis. CONSTITUTION: A pharmaceutical composition for preventing or treating osteoporosis contains mixture extract of Saururus chinensis and Scutellaria baicalensis as an active ingredient. The weight ratio of the Saururus chinensis and Scutellaria baicalensis is 1:10-10:1. A food composition for preventing and relieving osteoporosis contains mixture extract of Saururus chinensis and Scutellaria baicalensis as an active ingredient. A method for producing the mixture extract comprises: a step of washing Saururus chinensis and Scutellaria baicalensis with water and drying; a step of extracting the Saururus chinensis and Scutellaria baicalensis with solvent; a step of cooling the extract at room temperature and filtering; a step of decompress-concentrating and freeze-drying; and a step of mixing the extract of Saururus chinensis and Scutellaria baicalensis.

Abstract translation: 目的：提供含有Saururus chinensis和黄芩的混合物提取物的组合物，以抑制破骨细胞分化，增强骨密度和骨含量，并预防或治疗骨质疏松症。 构成：用于预防或治疗骨质疏松症的药物组合物含有中华黄牛和黄芩的混合物提取物作为活性成分。 中华黄牛和黄芩的重量比为1:10-10:1。 用于预防和缓解骨质疏松症的食物组合物含有中华黄芪和黄芩的混合物提取物作为活性成分。 制备混合物提取物的方法包括：用水洗涤中华黄芩和黄芩的步骤; 用溶剂萃取中华黄龙和黄芩的一步; 在室温下冷却提取物并过滤的步骤; 减压浓缩和冷冻干燥步骤; 并将中国黄芪和黄芩提取物混合在一起。

公开(公告)号：KR1020090064823A

公开(公告)日：2009-06-22

申请号：KR1020070132164

申请日：2007-12-17

Applicant: 한국화학연구원 ,  한국식품연구원

Inventor： 김영섭 ,  유시용 ,  연규환 ,  홍경식 ,  이병회 ,  이병호 ,  오광석 ,  서호원 ,  유대석 ,  최연희 ,  권대영

IPC: A61K36/185 ,  A61P9/08 ,  A61P9/12

Abstract: A composition for relaxing blood vessel which contains an Ulmus macrocarpa extract prevent and treat various cardiovascular diseases by inducing the relaxation of vascular smooth muscle. A pharmaceutical composition for relaxing blood vessel contains an Ulmus macrocarpa extract as an active ingredient. The composition is effective in preventing and treating hypertension, coronary artery disease, cerebrovascular disease, peripheral vascular disease, main artery disease, kidney dysfunction, cardiac insufficiency or vision disorder An organic solvent for extracting the Ulmus macrocarpa is selected from ethanol, ethanol solution, methanol, methanol solution, butanol, dichloromethane, ethyl acetate, hexane and their mixture. A health food having the effect of blood vessel relaxation contains Ulmus macrocarpa extract.

Abstract translation: 用于放松血管的组合物含有榆木提取物通过诱导血管平滑肌的松弛来预防和治疗各种心血管疾病。 用于放松血管的药物组合物含有榆木大pa提取物作为活性成分。 该组合物有效预防和治疗高血压，冠状动脉疾病，脑血管疾病，外周血管疾病，主动脉疾病，肾功能不全，心功能不全或视力障碍。用于提取榆树的有机溶剂选自乙醇，乙醇溶液，甲醇 ，甲醇溶液，丁醇，二氯甲烷，乙酸乙酯，己烷及其混合物。 具有血管松弛作用的保健食品包含榆树提取物。

公开(公告)号：KR1020080064238A

公开(公告)日：2008-07-09

申请号：KR1020070000902

申请日：2007-01-04

Applicant: 한국화학연구원 ,  한국식품연구원

Inventor： 김영섭 ,  유시용 ,  연규환 ,  홍경식 ,  이병회 ,  이병호 ,  오광석 ,  서호원 ,  서지희 ,  고우석 ,  권대영

IPC: A61K36/78 ,  A61P9/12

CPC classification number: A61K36/78 ,  A23L2/38 ,  A23L33/105 ,  A23V2002/00 ,  A61K31/065 ,  A61K31/36 ,  A23V2200/326 ,  A23V2250/21

Abstract: A composition comprising a root extract of Saururus chinensis or a compound isolated from the extract is provided to show excellent blood pressure lowering effect through vascular relaxation, thereby being usefully used as a pharmaceutical composition or a health food composition for preventing and treating various cardiovascular diseases caused by hypertension and complications of the hypertension. A pharmaceutical composition for vascular relaxation comprises a compound selected from the group consisting of machilin D, saucerneol D and a mixture thereof or a root extract of Saururus chinensis comprising the same compound as an effective ingredient, wherein the extract is prepared by using an organic solvent selected from the group consisting of ethanol, an aqueous solution of the ethanol, methanol, an aqueous solution of the methanol, butanol. dichloromethane, ethylacetate, hexane and a mixture thereof.

Abstract translation: 提供了包含中华鲟的根提取物或从提取物中分离的化合物的组合物，以通过血管松弛显示优异的降血压效果，从而有效地用作预防和治疗引起的各种心血管疾病的药物组合物或保健食品组合物 通过高血压和并发症的高血压。 用于血管松弛的药物组合物包含选自机体D，香草醇D及其混合物的化合物或包含与有效成分相同的化合物的中华黄瓜的根提取物，其中所述提取物通过使用有机溶剂 选自乙醇，乙醇水溶液，甲醇，甲醇水溶液，丁醇组成的组。 二氯甲烷，乙酸乙酯，己烷及其混合物。

公开(公告)号：KR100833654B1

公开(公告)日：2008-05-29

申请号：KR1020070013661

申请日：2007-02-09

Applicant: 한국화학연구원 ,  한국식품연구원

Inventor： 김영섭 ,  유시용 ,  연규환 ,  홍경식 ,  민용기 ,  김성환 ,  이병회 ,  최연희 ,  김현기 ,  권대영 ,  고우석

IPC: A61K36/78 ,  A61P19/10 ,  A61K31/341

CPC classification number: A61K36/78

Abstract: A composition comprising the extract of Saururus chinensis or active compounds isolated therefrom is provided to inhibit growth of osteoclast, so that the composition is useful for preventing or treating osteoporosis. A composition for preventing or treating osteoporosis comprises 0.01-30 wt.% of the extract of Saururus chinensis, which is prepared by extracting Saururus chinensis with C1-4 alcohol and its solution, dichloromethane, ethylacetate or a mixture thereof, or active compounds isolated from the Saururus chinensis extract including (-)-saucerneol represented by the formula(1) and sauristolactam represented by the formula(2), and is a pharmaceutical or health food composition having a formulation of beverage.

Abstract translation: 提供了包含中华黄牛提取物或从其分离的活性化合物的组合物以抑制破骨细胞的生长，使得该组合物可用于预防或治疗骨质疏松症。 用于预防或治疗骨质疏松症的组合物包括通过用C 1-4醇提取中华黄芪和其溶液，二氯甲烷，乙酸乙酯或其混合物或从其中分离的活性化合物制备的中华黄瓜提取物的0.01-30重量％ 含有由式（1）表示的（ - ） - 三氯蔗糖和由式（2）表示的沙拉耳内酰胺，是具有饮料配方的药物或保健食品组合物。

公开(公告)号：KR100833652B1

公开(公告)日：2008-05-29

申请号：KR1020060136696

申请日：2006-12-28

Applicant: 한국화학연구원 ,  한국식품연구원

Inventor： 김영섭 ,  유시용 ,  연규환 ,  홍경식 ,  박우규 ,  이병회 ,  유미영 ,  최연희 ,  권대영

IPC: C07D407/04

Abstract: A composition comprising the extract of Psoralea corylifolia seed or effective compounds contained therein is provided to inhibit the activity of BACE-1(beta-site APP(amyloid precursor protein)-cleaving enzyme 1) mediating the formation of beta-amyloid as a main causing material of dementia, so that the composition is useful for preventing or treating neurodegenerative disease. A composition for preventing or treating neurodegenerative disease comprises the extract of Psoralea corylifolia seed, which is prepared by extracting Psoralea corylifolia seeds with C1-4 alcohol or its solution, dichloromethane, ethylacetate or a mixture thereof, or a compound selected from 7-hydroxy-3-(4-methyl-4-(4-methylpentene-3-yl)-4H-chromen-6-yl)-4H-chromen-4-one represented by the formula(1), bakuchiol, bavachromene, isobavachromene, bavachalcone, isobavachalcone, bavachinin, 7,8-dihydro-8-(4-hydrophenyl)-2,2-dimethyl-2H,6H-[1,2-b:5,4-b']dipyran-6-one isolated from the extract of Psoralea corylifolia seed.

Abstract translation: 提供包含补骨脂素提取物或其中含有的有效化合物的组合物以抑制BACE-1（β-位点APP（淀粉样蛋白前体蛋白）切割酶1）的活性，其介导β-淀粉样蛋白的形成作为主要原因 因此该组合物可用于预防或治疗神经退行性疾病。 用于预防或治疗神经退行性疾病的组合物包括通过用C 1-4醇或其溶液，二氯甲烷，乙酸乙酯或其混合物或选自7-羟基-2-甲基苯酚的化合物提取茄科植物提取物的方法制备的补骨脂素提取物， 由式（1）表示的3-（4-甲基-4-（4-甲基戊烯-3-基）-4H-色烯-6-基）-4H-色烯-4-酮，苯甲酸，巴伐溴苯，异葎草酮，巴伐昔酮 ，异哈查酮，巴伐他丁，7,8-二氢-8-（4-氢苯基）-2,2-二甲基-2H，6H- [1,2-b：5,4-b']二吡喃-6-酮 茯苓提取物。